Janssen Pharms., Inc. v. Mylan Labs. Ltd.

Start
Invega Trinza® (paliperidone palmitate) – Case Name: Janssen Pharms., Inc. v. Mylan Labs. Ltd., No. 2023-2042, 2025 WL 946390 (Fed. Cir. Mar. 28, 2025) (Circuit Judges Dyk, Prost, and District Judge Goldberg presiding; Opinion by Dyk, C.J.) (Appeal from D.N.J., Padin, J.)….
By: Robins Kaplan LLP
Previous Story

Federal Agencies Ordered to Streamline Infrastructure Permits

Next Story

[Audio] Episode 365 — Four Sanctions Cases Everyone Should Know